Tumor Progression Locus 2 (Tpl2) Deficiency Does Not Protect against Obesity-Induced Metabolic Disease

• Graeme I. Lancaster ,

  * E-mail: graeme.lancaster@bakeridi.edu.au (GIL); banerjee@burnet.edu.au (AB)

  Affiliation Cellular and Molecular Metabolism Laboratory, BakerIDI Heart and Diabetes Institute, Melbourne, Australia

  ⨯
• Greg M. Kowalski,

  Affiliations Cellular and Molecular Metabolism Laboratory, BakerIDI Heart and Diabetes Institute, Melbourne, Australia, Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia

  ⨯
• Emma Estevez,

  Affiliation Cellular and Molecular Metabolism Laboratory, BakerIDI Heart and Diabetes Institute, Melbourne, Australia

  ⨯
• Michael J. Kraakman,

  Affiliations Cellular and Molecular Metabolism Laboratory, BakerIDI Heart and Diabetes Institute, Melbourne, Australia, Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia

  ⨯
• George Grigoriadis,

  Affiliations Intracellular Signalling and Gene Expression Laboratory, Burnet Institute, Melbourne, Australia, Department of Clinical Haematology, Central Clinical School, Monash University, Melbourne, Australia

  ⨯
• Mark A. Febbraio,

  Affiliation Cellular and Molecular Metabolism Laboratory, BakerIDI Heart and Diabetes Institute, Melbourne, Australia

  ⨯
• Steve Gerondakis,

  Affiliations Intracellular Signalling and Gene Expression Laboratory, Burnet Institute, Melbourne, Australia, Department of Clinical Haematology, Central Clinical School, Monash University, Melbourne, Australia

  ⨯
• Ashish Banerjee

  * E-mail: graeme.lancaster@bakeridi.edu.au (GIL); banerjee@burnet.edu.au (AB)

  Affiliations Intracellular Signalling and Gene Expression Laboratory, Burnet Institute, Melbourne, Australia, Department of Clinical Haematology, Central Clinical School, Monash University, Melbourne, Australia

  ⨯